CooperVision’s MiSight 1 day changed the game when it became widely available to Australian practitioners in 2016 for myopia management....
Read moreData has become one of the sharpest tools to inform the clinical and commercial aspects of optometry businesses in 2023....
Read moreApplying neuroscience technology to progressive ophthalmic lens design has led to a breakthrough for Tokai Optical, and it’s giving patients...
Read moreManaging myopia in children can be a different ball game in a public-facing clinic, opposed to those in a corporate,...
Read moreAt the completion of this article, the reader should be able to align their clinical protocols more closely to a...
Read moreIn recent years, cybercrimes targeting U.S. optometry practices have exposed personal health and financial information of millions of patients. Do...
Read moreThe co-owners of a greenfield Melbourne practice that opened in 2020 explain how they became the first and only optometrist...
Read moreThe outbreak of a lethal drug-resistant bacteria strain linked to an alleged eye drop manufacturing breakdown is one of the...
Read moreAnti-reflective coatings now do much more than the name suggests. HOYA is one lens lab focusing on properties that promote...
Read moreHow do you put nervous patients at ease? How do you set aside your own bias and assumptions to make...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited